Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic mortality factors in advanced light chain cardiac amyloidosis: A prospective cohort study.
Zaroui A, Kharoubi M, Gounot R, Oghina S, Degoutte C, Bezard M, Galat A, Guendouz S, Roulin L, Audard V, Leroy V, Teiger E, Poullot E, Molinier-Frenkel V, Le Bras F, Belhadj K, Bastard JP, Fellahi S, Shourick J, Lemonier F, Damy T. Zaroui A, et al. Among authors: bezard m. ESC Heart Fail. 2024 Jun;11(3):1707-1719. doi: 10.1002/ehf2.14671. Epub 2024 Mar 5. ESC Heart Fail. 2024. PMID: 38444090 Free PMC article.
Comparison of cardiac involvement, extracardiac manifestations and outcomes between homozygote and heterozygote transthyretin p.Val142Ile (V122I) variant in patients with hereditary transthyretin amyloidosis: a cohort study.
Albenque G, Bézard M, Kharoubi M, Odouard S, Lunati A, Poullot E, Zaroui A, Teiger E, Hittinger L, Audard V, El Karoui K, Funalot B, Fanen P, Damy T, Oghina S. Albenque G, et al. Among authors: bezard m. Amyloid. 2023 Dec;30(4):407-415. doi: 10.1080/13506129.2023.2227322. Epub 2023 Jun 28. Amyloid. 2023. PMID: 37377439
Amylo-AFFECT-QOL, a self-reported questionnaire to assess health-related quality of life and to determine the prognosis in cardiac amyloidosis.
Kharoubi M, Bézard M, Broussier A, Galat A, Gounot R, Poullot E, Molinier-Frenkel V, Fanen P, Funalot B, Itti E, Lemonnier F, Sing Chadha GD, Guendouz S, Mallet S, Zaroui A, Audard V, Audureau E, Le Corvoisier P, Hittinger L, Planté Bordeneuve V, Lefaucheur JP, Amiot A, Bequignon E, Bartier S, Leroy V, Teiger E, Oghina S, Damy T. Kharoubi M, et al. Among authors: bezard m. Front Cardiovasc Med. 2023 Mar 14;10:1124660. doi: 10.3389/fcvm.2023.1124660. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 36998975 Free PMC article.
Real-Life Evaluation of an Algorithm for the Diagnosis of Cardiac Amyloidosis.
Bézard M, Kharoubi M, Galat A, Le Bras F, Poullot E, Molinier-Frenkel V, Fanen P, Funalot B, Moktefi A, Abulizi M, Deux JF, Lemonnier F, Guendouz S, Chalard C, Zaroui A, Itti E, Hittinger L, Teiger E, Oghina S, Damy T. Bézard M, et al. Mayo Clin Proc. 2023 Jan;98(1):48-59. doi: 10.1016/j.mayocp.2022.08.016. Epub 2022 Dec 2. Mayo Clin Proc. 2023. PMID: 36464537
Prognosis of Transthyretin Cardiac Amyloidosis Without Heart Failure Symptoms.
Gonzalez-Lopez E, Escobar-Lopez L, Obici L, Saturi G, Bezard M, Saith SE, AbouEzzeddine OF, Mussinelli R, Gagliardi C, Kharoubi M, Griffin JM, Dispenzieri A, Vilches S, Perlini S, Longhi S, Oghina S, Rivas A, Grogan M, Maurer MS, Damy T, Palladini G, Rapezzi C, Garcia-Pavia P. Gonzalez-Lopez E, et al. Among authors: bezard m. JACC CardioOncol. 2022 Nov 15;4(4):442-454. doi: 10.1016/j.jaccao.2022.07.007. eCollection 2022 Nov. JACC CardioOncol. 2022. PMID: 36444226 Free PMC article.
Evaluation of a new ELISA assay for monoclonal free-light chain detection in patients with cardiac amyloidosis.
Abroud H, Beldi-Ferchiou A, Audard V, Lemonnier F, Le Bras F, Belhadj K, Moktefi A, Poullot E, El Karoui K, Dupuis J, Maarek A, Roulin L, Delfau-Larue MH, Oghina S, Kharoubi M, Bézard M, Zaroui A, Damy T, Molinier-Frenkel V. Abroud H, et al. Among authors: bezard m. EJHaem. 2022 Jun 24;3(3):828-837. doi: 10.1002/jha2.516. eCollection 2022 Aug. EJHaem. 2022. PMID: 36051065 Free PMC article.
Heart Transplantation, Either Alone or Combined With Liver and Kidney, a Viable Treatment Option for Selected Patients With Severe Cardiac Amyloidosis.
Guendouz S, Grimbert P, Radu C, Cherqui D, Salloum C, Mongardon N, Maghrebi S, Belhadj K, Le Bras F, Teiger E, Couetil JP, Balan A, Kharoubi M, Bézard M, Oghina S, Bodez D, Hittinger L, Audard V, Planté-Bordeneuve V, De la Taille A, Bergoend E, Frenkel V, Fanen P, Leroy V, Duvoux C, Carmagnat M, Folliguet T, Damy T. Guendouz S, et al. Among authors: bezard m. Transplant Direct. 2022 Jun 17;8(7):e1323. doi: 10.1097/TXD.0000000000001323. eCollection 2022 Jul. Transplant Direct. 2022. PMID: 35747521 Free PMC article.
29 results